Accueil > Actualité
Actualite financiere : Actualite bourse

bioMérieux: CE marking for new RT-PCR test

( - bioMérieux has announced the enhancement of its ARGENE range for the identification of SARS-CoV-2 in Real Time PCR (RT-PCR), with the SARS-COV-2 RESPI R-GENE test, which is now commercially available in Europe and in countries that recognise the CE mark.

This high-throughput test, which can be used on molecular biology platforms in both hospital and city laboratories, enables the simultaneous detection of SARS-CoV-2 and influenza A and B viruses.

In the same kit it combines a second RT-PCR assay which, from the same extraction, enables the identification of RSV (human respiratory syncytial virus) and hMPV (human metapneumovirus), which is more rarely included in panels.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.